These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1293 related items for PubMed ID: 11849452

  • 1. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA, Asplin JR, Grynpas MD, Evan AP, Parker WR, Alexander KM, Coe FL.
    Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
    [Abstract] [Full Text] [Related]

  • 2. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA, Parker WR, Asplin JR.
    Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA, Grynpas MD, Asplin JR.
    Kidney Int; 2001 Apr; 59(4):1415-23. PubMed ID: 11260403
    [Abstract] [Full Text] [Related]

  • 5. Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats.
    Evan AP, Bledsoe SB, Smith SB, Bushinsky DA.
    Kidney Int; 2004 Jan; 65(1):154-61. PubMed ID: 14675046
    [Abstract] [Full Text] [Related]

  • 6. Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats.
    Bushinsky DA, Bashir MA, Riordon DR, Nakagawa Y, Coe FL, Grynpas MD.
    Kidney Int; 1999 Feb; 55(2):602-12. PubMed ID: 9987084
    [Abstract] [Full Text] [Related]

  • 7. Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA, Laplante K, Asplin JR.
    Kidney Int; 2006 May; 69(9):1586-92. PubMed ID: 16557225
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, Carini M, Caudarella R, Ferraro M, Gambaro G, Gelosa M, Guttilla A, Illiano E, Martino M, Meschi T, Messa P, Miano R, Napodano G, Nouvenne A, Rendina D, Rocco F, Rosa M, Sanseverino R, Salerno A, Spatafora S, Tasca A, Ticinesi A, Travaglini F, Trinchieri A, Vespasiani G, Zattoni F, CLU Working Group.
    Arch Ital Urol Androl; 2015 Jul 07; 87(2):105-20. PubMed ID: 26150027
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Stone formation in genetic hypercalciuric rats.
    Bushinsky DA, Grynpas MD, Nilsson EL, Nakagawa Y, Coe FL.
    Kidney Int; 1995 Dec 07; 48(6):1705-13. PubMed ID: 8587230
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Chlorthalidone with potassium citrate decreases calcium oxalate stones and increases bone quality in genetic hypercalciuric stone-forming rats.
    Krieger NS, Asplin J, Granja I, Chen L, Spataru D, Wu TT, Grynpas M, Bushinsky DA.
    Kidney Int; 2021 May 07; 99(5):1118-1126. PubMed ID: 33417997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 65.